Galera has entered into an Asset Purchase Agreement with Toronto-based Biossil for Galera’s dismutase mimetics portfolio, including all avasopasem and rucosopasem formulations and indications. The ...
MALVERN, Pa., May 03, 2024 (GLOBE NEWSWIRE) -- Galera Therapeutics, Inc. (GRTX), a biopharmaceutical company focused on developing a pipeline of novel, proprietary therapeutics that have the potential ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results